172 related articles for article (PubMed ID: 33335800)
1. Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation.
Han SR; Lee CH; Im JY; Kim JH; Kim JH; Kim SJ; Cho YW; Kim E; Kim Y; Ryu JH; Ju MH; Jeong JS; Lee SW
Mol Ther Nucleic Acids; 2021 Mar; 23():154-168. PubMed ID: 33335800
[TBL] [Abstract][Full Text] [Related]
2. Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation.
Kim J; Won R; Ban G; Ju MH; Cho KS; Young Han S; Jeong JS; Lee SW
Sci Rep; 2015 Jul; 5():12315. PubMed ID: 26189916
[TBL] [Abstract][Full Text] [Related]
3. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.
Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW
Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435
[TBL] [Abstract][Full Text] [Related]
4. Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement.
Won YS; Jeong JS; Kim SJ; Ju MH; Lee SW
Cancer Lett; 2015 Jan; 356(2 Pt B):918-28. PubMed ID: 25444904
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.
Jeong JS; Lee SW; Hong SH; Lee YJ; Jung HI; Cho KS; Seo HH; Lee SJ; Park S; Song MS; Kim CM; Kim IH
Clin Cancer Res; 2008 Jan; 14(1):281-90. PubMed ID: 18172280
[TBL] [Abstract][Full Text] [Related]
6. Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme.
Song MS; Lee SW
FEBS Lett; 2006 Sep; 580(21):5033-43. PubMed ID: 16949075
[TBL] [Abstract][Full Text] [Related]
7. Cancer cell targeting with mouse TERT-specific group I intron of Tetrahymena thermophila.
Ban G; Song MS; Lee SW
J Microbiol Biotechnol; 2009 Sep; 19(9):1070-6. PubMed ID: 19809268
[TBL] [Abstract][Full Text] [Related]
8. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme.
Song MS; Jeong JS; Cho KS; Lee SW
Exp Mol Med; 2007 Dec; 39(6):722-32. PubMed ID: 18160843
[TBL] [Abstract][Full Text] [Related]
9. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript.
Kwon BS; Jung HS; Song MS; Cho KS; Kim SC; Kimm K; Jeong JS; Kim IH; Lee SW
Mol Ther; 2005 Nov; 12(5):824-34. PubMed ID: 16040278
[TBL] [Abstract][Full Text] [Related]
10. Cancer-specific induction of adenoviral E1A expression by group I intron-based trans-splicing ribozyme.
Won YS; Lee SW
J Microbiol Biotechnol; 2012 Mar; 22(3):431-5. PubMed ID: 22450801
[TBL] [Abstract][Full Text] [Related]
11. Selective and efficient retardation of cancers expressing cytoskeleton-associated protein 2 by targeted RNA replacement.
Ban G; Jeong JS; Kim A; Kim SJ; Han SY; Kim IH; Lee SW
Int J Cancer; 2011 Aug; 129(4):1018-29. PubMed ID: 21328343
[TBL] [Abstract][Full Text] [Related]
12. Targeted retardation of hepatocarcinoma cells by specific replacement of alpha-fetoprotein RNA.
Won YS; Lee SW
J Biotechnol; 2007 May; 129(4):614-9. PubMed ID: 17360066
[TBL] [Abstract][Full Text] [Related]
13. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
Hong SH; Jeong JS; Lee YJ; Jung HI; Cho KS; Kim CM; Kwon BS; Sullenger BA; Lee SW; Kim IH
Mol Ther; 2008 Jan; 16(1):74-80. PubMed ID: 17700543
[TBL] [Abstract][Full Text] [Related]
14. Specific and Efficient Regression of Cancers Harboring KRAS Mutation by Targeted RNA Replacement.
Kim SJ; Kim JH; Yang B; Jeong JS; Lee SW
Mol Ther; 2017 Feb; 25(2):356-367. PubMed ID: 28153088
[TBL] [Abstract][Full Text] [Related]
15. Selective expression of transgene using hypoxia-inducible trans-splicing group I intron ribozyme.
Kim SJ; Lee SW
J Biotechnol; 2014 Dec; 192 Pt A():22-7. PubMed ID: 25312327
[TBL] [Abstract][Full Text] [Related]
16. In vivo reprogramming of human telomerase reverse transcriptase (hTERT) by trans-splicing ribozyme to target tumor cells.
Lee SJ; Lee SW; Jeong JS; Kim IH
Methods Mol Biol; 2010; 629():307-21. PubMed ID: 20387158
[TBL] [Abstract][Full Text] [Related]
17. Image-aided Suicide Gene Therapy Utilizing Multifunctional hTERT-targeting Adenovirus for Clinical Translation in Hepatocellular Carcinoma.
Kim YH; Kim KT; Lee SJ; Hong SH; Moon JY; Yoon EK; Kim S; Kim EO; Kang SH; Kim SK; Choi SI; Goh SH; Kim D; Lee SW; Ju MH; Jeong JS; Kim IH
Theranostics; 2016; 6(3):357-68. PubMed ID: 26909111
[TBL] [Abstract][Full Text] [Related]
18. miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene Therapy.
Suzuki T; Sakurai F; Nakamura SI; Kouyama E; Kawabata K; Kondoh M; Yagi K; Mizuguchi H
Mol Ther; 2008 Oct; 16(10):1719-1726. PubMed ID: 28189004
[TBL] [Abstract][Full Text] [Related]
19. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy.
Suzuki T; Sakurai F; Nakamura S; Kouyama E; Kawabata K; Kondoh M; Yagi K; Mizuguchi H
Mol Ther; 2008 Oct; 16(10):1719-26. PubMed ID: 18665157
[TBL] [Abstract][Full Text] [Related]
20. Ribozyme-mediated selective killing of cancer cells expressing carcinoembryonic antigen RNA by targeted trans-splicing.
Jung HS; Lee SW
Biochem Biophys Res Commun; 2006 Oct; 349(2):556-63. PubMed ID: 16945335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
